ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
![]() |
Àü½Å¼º ¼Ò¾ÆÆ¯¹ß¼º°üÀý¿° ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Ä¡·á À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030F)
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
À¯À×À°Á¾ ½ÃÀå - ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(2034³â)
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
WHIM ÁõÈıº ½ÃÀå - ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ, ½ÃÀå ¿¹Ãø(2034³â)
WHIM Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
¼¼°èÀÇ ¿ø»Ô¼¼Æ÷ ÀÌ¿µ¾çÁõ ½ÃÀå : À¯Çüº°, Ä¡·á À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®, ±Ô¸ð, µ¿Çâ, COVID-19ÀÇ ¿µÇâ, ¿¹Ãø(-2030³â)
Global Cone Rod Dystrophy Market: Analysis By Type, By Treatment Type, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 2,250
![]() |
![]() |
½ºÅ¸°¡¸£Æ®º´ Ä¡·áÁ¦ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¾à¹° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Stargardt Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Distribution Channel, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ µµÆÄ¹Î ÀÛ¿ëÁ¦ ½ÃÀå : ½ÃÀå ±Ô¸ðÀÇ ºÐ¼® ¹× ¿¹Ãø - Åõ¿© °æ·Îº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°(2022-2032³â)
Global Dopamine Agonist Market Size Study, by Drug (Non-ergot Dopamine Agonists, Ergot Alkaloids), by Route of Administration (Oral, Injectable), by Application, by Distribution Channel, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,950
![]() |
![]() |
ÃÊ´ë °£¼¼Æ÷ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Primary Hepatocytes Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,995
![]() |
![]() |
¼¼°èÀÇ 3-Ű³ª¾ÆÁ¦ µ¨Å¸ ÁõÈıº ½ÃÀå : Ä¡·á, Åõ¿© ¹æ¹ý, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(2025-2030³â)
3-Kinase Delta Syndrome Market by Treatment, Mode of Administration, End-Use - Global Forecast 2025-2030
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¼¼°èÀÇ WHIM ÁõÈıº ½ÃÀå : Ä¡·á¹ý, Åõ¿© ¹æ¹ý, Ä¡·á ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
WHIM Syndrome Market by Treatment, Mode of Administration, Therapeutic Application, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¼¼°èÀÇ ºñ°áÇÙ¼º Ç×»ê±Õ °¨¿°Áõ ½ÃÀå(2025³â)
Nontuberculous Mycobacterial Infection Global Market Report 2025
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ µ¥³ë¼ö¸¿(Denosmab) ½ÃÀå º¸°í¼(2025)
Denosumab Global Market Report 2025
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ »çÀÌŬ¸° ÀÇÁ¸¼º Ű³ª¾ÆÁ¦(CDK) 4/6 ¾ïÁ¦Á¦ ½ÃÀå º¸°í¼(2025³â)
Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Global Market Report 2025
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ¸»´Üºñ´ëÁõ ½ÃÀå º¸°í¼(2025³â)
Acromegaly Global Market Report 2025
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ¸»´Üºñ´ëÁõ Ä¡·á ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2033³â)
Global Acromegaly Treatment Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 3,920
![]() |
![]() |
µµÆÄ¹Î ÀÛ¿ëÁ¦ ½ÃÀå : ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼ - ¾àÁ¦º°, Åõ¿© °æ·Îº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Dopamine Agonist Market Size, Share & Trends Analysis Report By Drug (Non-ergot Dopamine Agonists, Ergot Alkaloids), By Route Of Administration (Oral, Injectable), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 5,950
![]() |
![]() |
¾î¼ÅÁõÈıº Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Áúȯ À¯Çüº°, Ä¡·á À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Usher Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type, By Treatment Type, By End-User By Region & Competition, 2020-2030F
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
Çö󽺹̳ë°Õ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, À¯Çüº°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Plasminogen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
½Â¸ðÆÇ¸· Áúȯ ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, Ä¡·á À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Mitral Valve Disease Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Treatment Type, By Indication, By End-User, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀådlswk(FGF) ½ÃÀå(2025-2033³â)
Global Fibroblast Growth Factors (FGFs) Market - 2025-2033
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,350
![]() |
![]() |
±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨ : ±¹°¡º° Áúȯ À¯º´·ü µ¥ÀÌÅÍ(2024³â)
2024 Refractive Error Disease Model: Country-Level Disease Prevalence Data
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 9,250
![]() |
![]() |
¿åâ Ä¡·á ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Pressure Ulcers Treatment Market, By Product Type, By End User, By Geography
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ ÇìÆÄ¸° À¯µµ Ç÷¼ÒÆÇ °¨¼ÒÁõ ½ÃÀå(2025-2033³â)
Global Heparin-Induced Thrombocytopenia Market - 2025-2033
¹ßÇà 2025³â 02¿ù
°¡°Ý
US $ 4,350
![]() |
![]() |
¼¼°èÀÇ Æ¯¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ(¸é¿ª¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ) - ÀÓ»ó½ÃÇè ¸®ºä(2025³â)
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Global Clinical Trials Review, 2025
¹ßÇà 2025³â 01¿ù
°¡°Ý
US $ 3,450
![]() |
![]() |
¸»´Üºñ´ëÁõ Ä¡·á ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - ¾àÁ¦ Ŭ·¡½ºº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 01¿ù
°¡°Ý
US $ 5,950
![]() |
![]() |
GLP-1 ½ÃÀå : ºÐÀÚ À¯Çüº°, »ç¿ëµÇ´Â Ȱ¼ºÈÇÕ¹°º°, GLP-1 ¾Æ°í´Ï½ºÆ® ÀǾàǰ À¯Çüº°, ¾Æ°í´Ï½ºÆ® À¯Çüº°, Åõ¿© °æ·Îº°, Ç¥Àû ÀûÀÀÁõº°, ÁÖ¿ä Áö¿ªº° - ¾÷°è µ¿Çâ°ú ¼¼°è ¿¹Ãø(-2035³â)
GLP-1 Market by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist Route of Administration, Target indication and Key Geographical Regions : Industry Trends and Global Forecasts, Till 2035
¹ßÇà 2025³â 01¿ù
°¡°Ý
US $ 4,799
![]() |